NASDAQ, THOR - Synthorx Inc
We are a leading manufacturer of circulatory support products for use by
patients with congestive heart failure, or CHF. We are a leading provider of
circulatory support products worldwide. We sell Ventricular Assist Devices, or
VADs, to virtually every leading heart transplant center in the world; marketing
three out of the four VADs approved by the United States Food and Drug
Administration, or FDA, as a bridge to heart transplant for adults. We are also
a leading provider of point-of-care blood diagnostic test systems.
Our business is comprised of two segments; Cardiovascular and ITC. The major
product lines within the Cardiovascular market are:
? Circulatory Support Products. Our circulatory support products include VADs
for the short-term and long-term treatment of congestive heart failure.
? Vascular Graft Products. ...
Read SEC Filing on NASDAQ.com »